Search

Your search keyword '"Oger, Emmanuel"' showing total 777 results
Start Over Author "Oger, Emmanuel"
777 results on '"Oger, Emmanuel"'

1. Cost-effectiveness of weekly adaptive radiotherapy versus standard IMRT in head and neck cancer alongside the ARTIX trial

Author

Perrier, Lionel, Balusson, Frédéric, Morelle, Magali, Castelli, Joël, Thariat, Juliette, Benezery, Karen, Hasbini, Ali, Gery, Bernard, Berger, Antoine, Liem, Xavier, Guihard, Sébastien, Chapet, Sophie, Thureau, Sébastien, Auberdiac, Pierre, Pommier, Pascal, Ruffier, Amandine, Devillers, Anne, Oger, Emmanuel, Campillo-Gimenez, Boris, and de Crevoisier, Renaud

Published
2024
Full Text
View/download PDF

3. Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial

Author

Zuily, Stéphane, Couturaud, Francis, Goehringer, François, Laporte, Silvy, Mismetti, Patrick, Presles, Emilie, Rossignol, Patrick, Thilly, Nathalie, Wahl, Denis, Lecompte, Thomas, Oger, Emmanuel, Sevestre, Marie-Antoinette, Parent, Florence, Benhamou, Ygal, Roy, Pierre-Marie, Gigante, Tristan, Gilg, Morgane, Maclot, Pierre-Luc, Rossignol, Bénédicte, Udot, Jonathan, Bouteille, Hélène, Buchmuller, Andréa, Peurière, Céline, Siaghy, El Mehdi, Bouaziz, Valérie, Daguin, Charlotte, Grosjean, Benjamin, Saunier, Véronique, Verger, Laurence, Jacquot, Madlyne, Petitpain, Nadine, Charly, Martin, Tordella, Laurent, Baronnet, Guillaume, Baux, Elisabeth, Benetos, Athanase, Blanvillain, Jean-Baptiste, Conrad, Marie, Courte, Guilhem, Cravoisy-Popovic, Aurélie, Dufrost, Virginie, Gibot, Sébastien, Guerci, Philippe, Joly, Laure, Kimmoun, Antoine, Koszutski, Matthieu, Larue, Alexandrine, Levy, Bruno, Losser, Marie-Reine, Mattei, Mathieu, Nace, Lionel, Novy, Emmanuel, Perez, Pierre, Pertek, Jean-Pierre, Rigaux, Camille, Sauvage, Alexis, Schvoerer, Evelyne, Thivilier, Carine, Volkov, Lev, Zieminski, Piotr, Benlounes, Manil, Cheng, Charles, Fréminville, Jean-Baptiste de, Détriché, Grégoire, Flammarion, Emmanuel, Goudot, Guillaume, Hamdan, Amer, Hindré, Raphaël, Manoli, Corina, Messas, Emmanuel, Michon, Adrien, Mirault, Tristan, Pastré, Jean, Penet, Marie-Aude, Planquette, Benjamin, Volle, Geoffroy, Hamdan, Rémy, Laubriet-Jazayeri, Aline, Petit, Vincent, Piroth, Lionel, Quenot, Jean Pierre, Saccu, Mélissa, Barraud, Damien, Cavalli, Zoé, Gaci, Rostane, Andreu, Mathilde, Bertoletti, Laurent, De Magalhaes, Elodie, Bulifon, Sophie, Boucly, Athénaïs, Ebstein, Nathan, Humbert, Marc, Jaïs, Xavier, Jevnikar, Mitja, Savale, Laurent, Seferian, Andrei Horia, Colin, Charlotte, Ganem, Timothée, Roumila, Mehdi, Chopard, Romain, Besutti, Matthieu, Mouhat, Basile, Andrejak, Claire, Dupas, Stéphane, Le Roy, Gaëlle, Samy-Modeliar, Santhi, Coste, Anne, Fauche, Alexandre, Goetghebeur, David, Gut-Gobert, Christophe, Hoffmann, Clément, Hourmant, Baptiste, L'hévéder, Cécile, Lemoigne, Emmanuelle, Nepveu, Olivier, Paret, Raphaël, Picart, Gaël, Azerkan, Saïd, Boudaa, Chadia, Campagne, Julien, Eszto, Peter, Godbert, Benoît, Guichard, Jean-François, Heschung, Marion, Legoff, Antoine, Mariot, Jacques, Martin, Pascale, Mercy, Magalie, Perrin, Julie, Raymond, Stéphane, Vernier, Nathalie, Fesler, Pierre, Henneton, Pierrick, Mercuzot, Cédric, Pansu, Nathalie, Perez, Lucas, Andre, Loïc, Bakhache, Edgar, Chopin, Marie-Charlotte, Gilbert, Marie, Lambert, Marc, Pokeerbux, Mohammad Ryadh, Danion, François, Hansmann, Yves, Rougier, Estelle, Ruch, Yvon, Stéphan, Dominique, Ursenbach, Axel, Connerade, Isabelle, Gravier, Simon, Kayser, Damien, Michel, Jean-Marc, Mohseni, Mahsa, Younes, Waël, Burlacu, Ruxandra, Lopes, Amanda, Mouly, Stéphane, Nassarmadji, Kladoum, Sène, Damien, Siguret, Virginie, Stepanian, Alain, Annweiler, Cédric, Brangier, Antoine, Dubee, Vincent, Henni, Samir, Hersant, Jeanne, Loison, Jocelyne, Kern, Léa, Laine, Jean-Baptiste, Neveux-Brecheteau, Claire, Perez, Lucia, Benainous, Ruben, Giroux-Leprieur, Bénédicte, Lopez-Sublet, Marilucy, Khaled-Jousselin, Saïda, Bernard, Yohann, Amiot, Amélie, Breistroff, Jessica, Detry, Emilie, Diallo, Kadidiatou, Didier, Agnès, Dumont, Nathalie, Egensperger, Julie, Emmerich, Aurélie, François, Nelly, Gallo, Fanny, George, Valérie, Gérome, Quentin, Gutehrle, Aurélie, Lehman, Laure, Petit, Séverine, Piard, Vanessa, Saint-Gilles, Maximilien, Terenzi, Olivier, Marquette, Amélie, Mortelette, Hélène, Audry, Mathilde, Cransac, Amélie, Maillard, Marine, Boyer, Anaïs, Gallo, Floriana, Urbing, Arielle, Zahaf, Imane, Byczko, Alexandra, Chaalal, Amina, Berlier, Georgette, Bernabe, Corinne, Bezzeghoud, Souad, Chaudier, Caroline, Chauvet, Carole, Davier, Marina, Labruyere, Carine, Perrin, Estelle, Pierre, Michaël, Chekirine, Claire-Annissa, Voivret, Florence, Meftali, Ramdane, Sabri, Ouaffa, Beulaygue, Anaïs, Gall, Julie, Girard, Laure, Haddaoui, Soumia, Rami, Scheherazade, Couderc, Auriane, Le Breton, Aude, Perruche, Marie-Line, Claudon, Cindy, Roussel, Ludivine, Barnier, Aude, Blanchard, Tiphaine, Le Gall, Bénédicte, Pelouin, Mélanie, Veillon, Anne-Sophie, Aquereburu, Quam, Delaygue, Charlène, Ait Idir, Zahoua, Drugeon, Jérémy, Dubrulle, Déborah, Tezkratt, Rabah, Frantz, Anne-Sophie, Drouaine, Julie, Dubois, Jacqueline, Eyriey, Magali, Haerrel, Elina, Beaudenon, Mélinda, Guenet, Mialy, Lecerf, Thibaud, Marechal-Girault, Stéphanie, Rehaiem, Sami, Simon, Romain, Dangeul-Potier, Florence, Goulvent, Morgane, Fliss, Souha, Messani, Fadhila, Mizejewski, Béatrice, Mugnier, Brigitte, Opderbeck, Valérie, Risse, Brigitte, Lefèvre, Benjamin, Sanchez, Olivier, Empis de Vendin, Ombeline, de Ciancio, Guillaume, Arlet, Jean-Benoît, Khider, Lina, Terriat, Béatrice, Greigert, Hélène, Robert, Céline S., Louis, Guillaume, Trinh-Duc, Albert, Rispal, Patrick, Accassat, Sandrine, Thiery, Guillaume, Montani, David, Azarian, Réza, Meneveau, Nicolas, Soudet, Simon, Le Mao, Raphaël, Maurier, François, Le Moing, Vincent, Quéré, Isabelle, Yelnik, Cécile M., Lefebvre, Nicolas, Martinot, Martin, and Delrue, Maxime

Published
2023
Full Text
View/download PDF

10. Randomised study for the Optimal Treatment of symptomatic patients with low-gradient severe Aortic valve Stenosis and preserved left ventricular ejection fraction (ROTAS trial).

Author

Galli, Elena, Le Ven, Florent, Coisne, Augustin, Sportouch, Catherine, Le Tourneau, Thierry, Lavie-Badie, Yoan, Bernard, Anne, Eicher, Jean-Christophe, Dreyfus, Julien, Ternacle, Julien, Baleynaud, Serge, Auffret, Vincent, Le Pabic, Estelle, Pibarot, Philippe, Oger, Emmanuel, and Donal, Erwan

Subjects
GLOBAL longitudinal strain, VENTRICULAR ejection fraction, HEART valve prosthesis implantation, AORTIC valve diseases, COVID-19 pandemic, AORTIC stenosis, HEART failure
Published
2024
Full Text
View/download PDF

17. Clinical and histological features of histiocytoid Sweet syndrome associated with VEXAS syndrome.

Author

Lecoeuvre, Hortense, Gall, François Le, Naoures, Cécile Le, Vignon-Pennamen, Marie-Dominique, Lamaison, Claire, Kammerer-Jacquet, Solène-Florence, Lescoat, Alain, Oger, Emmanuel, Pastoret, Cédric, and Dupuy, Alain

Subjects
SWEET'S syndrome, ACADEMIC medical centers, POLYMERASE chain reaction, CUTANEOUS manifestations of general diseases, C-reactive protein
Abstract

Background VEXAS (Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is caused by acquired somatic mutations in UBA1. Sweet-syndrome-like skin disorders [and especially histiocytoid Sweet syndrome (HSS)] may be associated with VEXAS syndrome. Objectives To characterize the clinical and histopathological features of HSS in patients with VEXAS syndrome. Methods Skin biopsies with a histological diagnosis of HSS at Rennes University Medical Center (Rennes, France) between October 2011 and January 2022 were reviewed in this study. Sanger sequencing and digital polymerase chain reaction were used to screen skin, blood and bone marrow samples for UBA1 variants, and thus classify patients as having VEXAS syndrome or not. We evaluated the clinical, histological and molecular (UBA1) characteristics of patients with or without VEXAS syndrome. Results We compared 15 skin biopsies from 7 patients found to have VEXAS syndrome and 19 skin biopsies from 15 patients without VEXAS syndrome. Persistent C-reactive protein elevation, macrocytosis, anaemia and haematological malignancies were more prevalent in patients with VEXAS syndrome [6/7 (86%), 6/7 (86%), 7/7 (100%) and 6/7 (86%), respectively] than in patients without [5/14 (36%), 6/15 (40%), 8/15 (53%) and 8/15 (53%), respectively]. These features sometimes appeared after the first skin manifestations, and a UBA1 mutation was found in the skin of five patients with VEXAS syndrome. Dermal infiltration by reniform histiocytoid cells (myeloperoxidase-positive and/or CD163-positive) and a periadnexal distribution were more frequently observed in VEXAS syndrome biopsies [15/15 (100%) and 3/15 (20%), respectively, vs. 11/19 (58%) and 0/19 (0%) in non-VEXAS syndrome biopsies, respectively]. Conclusions Our findings might help pathologists to consider a diagnosis of VEXAS syndrome and to initiate early genetic testing. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

19. Transcatheter aortic valve implantation in severe aortic stenosis does not necessarily reverse left ventricular myocardial damage: data of long-term follow-up.

Author

Myon, Frederic, Marut, Benjamin, Kosmala, Wojciech, Auffret, Vincent, Leurent, Guillaume, L'official, Guillaume, Curtis, Elizabeth, Breton, Herve Le, Oger, Emmanuel, and Donal, Erwan

Subjects
CROSS-sectional method, CORONARY disease, VENTRICULAR ejection fraction, SCIENTIFIC observation, TREATMENT effectiveness, DESCRIPTIVE statistics, HEART valve prosthesis implantation, AORTIC stenosis, MYOCARDIUM, LEFT ventricular dysfunction, PATIENT aftercare
Abstract

Aims Aortic stenosis (AS) is causing myocardial damage and replacement is mainly indicated based on symptoms. Non-invasive estimation of myocardial work (MW) provides a less afterload-dependent too for assessing myocardial function. We sought to look at the impact of transcatheter aortic valve implantation (TAVI) on the myocardium at long-term follow-up and according to current indications. Methods and results We conducted an observational, cross-sectional, single-centre study. Patients were selected based on the validated indication for a TAVI. Standardized echocardiographies were repeated. A total of 102 patients were included. The mean age was 85 years, 45% were female, 68% had high blood pressure, and 52% had a coronary disease. One-fifth was suffering from low-flow–low-gradient AS. A follow-up was performed at 22 ± 9.5 months after the TAVI. No TAVI dysfunction was observed. Left ventricular (LV) ejection fraction was stable (62 ± 8%), and global longitudinal strain had improved (−14.0 ± 3.7 vs. −16.0 ± 3.6%, P < 0.0001). No improvement of the MW parameters was noticed (LV global work index 2099 ± 692 vs. 2066 ± 706 mmHg%, P = 0.8, LV global constructive 2463 ± 736 vs. 2463 ± 676 mmHg%, P = 0.8). Global wasted work increased [214 (149; 357) vs. 247 (177; 394) mmHg%, P = 0.0008]. Conclusion In a population of severe symptomatic AS patients who had undergone a TAVI, the non-invasive myocardial indices that assess the LV performance at long-term follow-up did not improve. These results are questioning the timing of the intervention and the need for more attention in the pharmacological management of these AS patients. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

27. Evolution and prognostic value of left ventricular deformation and myocardial work parameters in transthyretin amyloid cardiomyopathy.

Author

Antonelli, Jerome, Neveu, Antoine, Kosmala, Wojciech, L'Official, Guillaume, Curtis, Elizabeth, Oger, Emmanuel, and Donal, Erwan

Subjects
LEFT heart ventricle, CARDIOMYOPATHIES, HOSPITAL care, AMYLOIDOSIS, HEART physiology, HEART failure, MULTIVARIATE analysis, COMPARATIVE studies, SERUM albumin, ECHOCARDIOGRAPHY, GLOBAL longitudinal strain
Abstract

Aims Wild-type transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly recognized condition. It remains challenging to estimate the extent of disease and the prognosis for most patients. Myocardial work is a sensitive echocardiographic approach that improves the characterization of myocardial damage. We investigate the parameters of myocardial deformation and work in ATTR-CM patients and their changes over time. Methods and results We analysed clinical, electrocardiographic, biological, and echocardiographic characteristics in 113 patients [median age 82 (77–85), 90.4% male] diagnosed with wild-type ATTR-CM based on international consensus at a single centre. We compared the data at baseline and 18-month follow-up. Thirty-four patients died and 12 were hospitalized for heart failure at a median follow-up of 935 days (interquartile range 691–1159 days). Left ventricular end-diastolic diameter, left atrial strain during reservoir phase (LASRES), left ventricular longitudinal strain, global work index (GWI), global constructive work significantly decreased from baseline to 18 months, while left ventricular wall thickness increased. Left ventricular ejection fraction, right ventricular free wall strain (FWS), global wasted work (GWW), and global work efficiency did not alter significantly. Strain parameters were identified as prognostic on baseline evaluation using a multivariate analysis: GWI, GWW, FWS, and LASRES. They were significantly associated with the risk of death and hospitalization for heart failure. Conclusion Multi-chamber strain assessment may improve the surveillance of patients with ATTR-CM, and myocardial work parameters may improve clinical risk stratification in this population. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

29. Cox regression with linked data

Author

Vo, Thanh Huan, primary, Garès, Valérie, additional, Zhang, Li‐Chun, additional, Happe, André, additional, Oger, Emmanuel, additional, Paquelet, Stéphane, additional, and Chauvet, Guillaume, additional

Published
2023
Full Text
View/download PDF

31. French dermatologists' opinions and practices with regard to adjuvant therapy in stage III melanoma

Author

Rolland, Marion, primary, Oger, Emmanuel, additional, Dinulescu, Monica, additional, Lesimple, Thierry, additional, Russo, David, additional, Pracht, Marc, additional, Porneuf, Marc, additional, Dalac, Sophie, additional, Giacchero, Damien, additional, Jouary, Thomas, additional, Lebbé, Celeste, additional, Leccia, Marie-Thérèse, additional, Maubec, Eve, additional, Meyer, Nicolas, additional, Mortier, Laurent, additional, and Dupuy, Alain, additional

Published
2023
Full Text
View/download PDF

36. Primary mitral regurgitation: Toward a better quantification on left ventricular consequences.

Author

Neveu, Antoine, Aghezzaf, Samy, Oger, Emmanuel, L'official, Guillaume, Curtis, Elizabeth, Galli, Elena, Montaigne, David, Coisne, Augustin, and Donal, Erwan

Subjects
SPECKLE tracking echocardiography, STRESS echocardiography, GLOBAL longitudinal strain, ASYMPTOMATIC patients, LEFT heart atrium, PULMONARY artery, MITRAL valve insufficiency
Abstract

Background: Left ventricular end‐systolic diameter (LVESD) and ejection fraction (LVEF) are the parameters to look for when discussing repair in asymptomatic patients with a primary mitral regurgitation (PMR). Loading conditions are altering LV‐function quantification. LV‐myocardial work (LVMW) is a method based on pressure‐strain loops. Hypothesis: We sought to evaluate the additive value of the LVMW for predicting clinical events in patients with PMR. Methods: 103 patients (66% men, median age 57 years) with asymptomatic severe PMR were explored at rest and during an exercise stress echocardiography. LV myocardial global work index (GWI), constructive work (GCW), wasted work (GWW), and work efficiency (GWE) were measured with speckle‐tracking echocardiography at rest and low workload. The indication for surgery was based on the heart teams' decision. The median follow‐up was 670 days. Results: Clinical events occurred for 50 patients (48.5%) with a median of event‐free survival distribution of 289 days. Systolic pulmonary artery pressure (sPAP) at rest was 32.61 ± 8.56 mmHg and did not predict the risk of event like LVEF and LVESD. Changes in, GLS (hazard ratio [HR] 0.55; 95% confidence interval (Cl): 0.36–0.83; p =.005), GWI (HR 1.01; 95% Cl: 1.00–1.02; p =.002) and GCW (HR 1.85; 95% Cl: 1.28–2.68; p =.001) in addition to Left Atrial Volume Index (HR 1.73; 95% CI: 1.28 – 2.33; p < 0,001) were independent predictors of events. Conclusion: Changes in myocardial work indices related to low‐dose exercise are relevant to best predict PMR patient prognosis It might help to better select patient's candidate for "early‐surgery." [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

37. Cox regression with linked data.

Author

Vo, Thanh Huan, Garès, Valérie, Zhang, Li‐Chun, Happe, André, Oger, Emmanuel, Paquelet, Stéphane, and Chauvet, Guillaume

Subjects
MONTE Carlo method, DATABASES, STATISTICAL models, REGRESSION analysis, EPIDEMIOLOGICAL research
Abstract

Record linkage is increasingly used, especially in medical studies, to combine data from different databases that refer to the same entities. The linked data can bring analysts novel and valuable knowledge that is impossible to obtain from a single database. However, linkage errors are usually unavoidable, regardless of record linkage methods, and ignoring these errors may lead to biased estimates. While different methods have been developed to deal with the linkage errors in the generalized linear model, there is not much interest on Cox regression model, although this is one of the most important statistical models in clinical and epidemiological research. In this work, we propose an adjusted estimating equation for secondary Cox regression analysis, where linked data have been prepared by a third‐party operator, and no information on matching variables is available to the analyst. Through a Monte Carlo simulation study, the proposed method is shown to lead to substantial bias reductions in the estimation of the parameters of the Cox model caused by false links. An asymptotically unbiased variance estimator for the adjusted estimators of Cox regression coefficients is also proposed. Finally, the proposed method is applied to a linked database from the Brest stroke registry in France. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

38. Major adverse cardiovascular events in patients treated with oral Janus kinase inhibitors for atopic dermatitis: a systematic review and meta-analysis

Author

Ertus, Cécile, Scailteux, Lucie-Marie, Lescoat, Alain, Berthe, Pauline, Auffret, Vincent, Dupuy, Alain, Oger, Emmanuel, Droitcourt, Catherine, CHU Pontchaillou [Rennes], Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Laboratoire Traitement du Signal et de l'Image (LTSI), and Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)

Subjects
[SDV.IB]Life Sciences [q-bio]/Bioengineering
Abstract

International audience; BACKGROUND: On the basis of safety data on patients with inflammatory rheumatism or inflammatory bowel disease, treatment with Janus kinase (JAK) inhibitors has been linked to the occurrence of major adverse cardiovascular events (MACEs). However, these inflammatory diseases are pro-atherogenic; in contrast, patients with atopic dermatitis (AD) do not usually have a high cardiovascular (CV) comorbidity burden. METHODS: We systematically searched the PubMed, Embase, Cochrane Library and Google Scholar databases from their inception to September 2nd, 2022. Cohort studies, randomized controlled trials and pooled safety analyses providing CV safety data on patients taking JAK inhibitors for AD were selected. We included patients aged 12 and over. We built a "controlled-period" cohort (9,309 patients: 6,000 exposed to JAK inhibitors and 3,309 exposed to comparators) and an "all JAK inhibitors" cohort (9,118 patients exposed to a JAK inhibitor in any of the included studies). The primary outcome was a composite of acute coronary syndrome (ACS), ischemic stroke, and CV death. The broader secondary MACE outcome encompassed ACS, stroke (whether ischemic or hemorrhagic), transient ischemic attack, and CV death. The frequency of primary and secondary MACEs was assessed in both cohorts. A fixed-effects meta-analysis using Peto’s method was used to calculate the odds ratio (OR) [95% confidence interval (CI)] for MACEs in the "controlled-period" cohort. Risk of bias evaluation was made using the Cochrane Risk of bias tool version 2. Certainty of evidence used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. RESULTS: Eight percent of the initially identified records met the selection criteria, corresponding to 23 records included in the "all JAK inhibitors" cohort". The patients had been exposed to baricitinib, upadacitinib, abrocitinib, ivarmacitinib, placebo or dupilumab. Four primary events (3 with JAK inhibitors and 1 with placebo) and 5 secondary events (4 with JAK inhibitors and 1 with placebo) occurred among 9,309 patients in the "controlled-period" cohort (MACE frequency = 0.04 % and 0.05%, respectively). Eight primary events and 13 secondary events occurred among 9,118 patients in the "all JAK inhibitors" cohort (MACE frequency = 0.08 and 0.14 %, respectively). Odds ratio for primary MACEs in patients with AD treated with JAK inhibitors compared to placebo or dupilumab was 1.35 (95% CI 0.15-12.21; I2, 12%, very low certainty of evidence). CONCLUSION: Our review highlighted rare cases of MACE among JAK inhibitors users for AD. Janus kinase inhibitors may have little to no effect on the occurrence of MACEs in patients with AD compared to comparators but the evidence is very uncertain. Real-life, long-term, population-level safety studies are needed.

Published
2023

40. Evolution of non-invasive myocardial work variables after transcatheter aortic valve implantation in patients with severe aortic stenosis

Author

Quinio, Louis, primary, Taconne, Marion, additional, Le Rolle, Virginie, additional, Curtis, Libby, additional, Auffret, Vincent, additional, Boulmier, Dominique, additional, Leurent, Guillaume, additional, Le Breton, Hervé, additional, Galli, Elena, additional, Oger, Emmanuel, additional, and Donal, Erwan, additional

Published
2023
Full Text
View/download PDF

41. Long‐term outcomes in heart failure with preserved ejection fraction: Predictors of cardiac and non‐cardiac mortality

Author

Shahim, Angiza, primary, Hourqueig, Marion, additional, Lund, Lars H., additional, Savarese, Gianluigi, additional, Oger, Emmanuel, additional, Venkateshvaran, Ashwin, additional, Benson, Lina, additional, Daubert, Jean‐Claude, additional, Linde, Cecilia, additional, Donal, Erwan, additional, and Hage, Camilla, additional

Published
2023
Full Text
View/download PDF

42. Safety and Feasibility of Laparoscopic Nephrectomy for Big Tumors (≥ 10 cm): A Retrospective Multicentric Study

Author

Verhoest, Grégory, Couapel, Jean-Philippe, Oger, Emmanuel, Rioux-Leclercq, Nathalie, Pignot, Géraldine, Patard, Jean-Jacques, Bex, Axel, Panayotopoulos, Paul, Bigot, Pierre, Eret, Viktor, Hora, Milan, Turna, Burak, Lefevre, Maxime, Rigaud, Jérôme, Tillou, Xavier, Doerfler, Arnaud, Xylinas, Evanguelos, Soorojebally, Yanish, Rouprêt, Morgan, Lagabrielle, Samuel, Bernhard, Jean-Christophe, Long, Jean-Alexandre, Berger, Julien, Ravier, Emmanuel, Paparel, Philippe, Salomon, Laurent, Rodriguez, Alejandro R., and Bensalah, Karim

Published
2016
Full Text
View/download PDF

43. Safety of prasugrel in real-world patients with ST-segment elevation myocardial infarction: 1-year results from a prospective observational study (Bleeding and Myocardial Infarction Study)

Author

Bacquelin, Raoul, Oger, Emmanuel, Filippi, Emmanuelle, Hacot, Jean-Philippe, Auffret, Vincent, Le Guellec, Marielle, Coudert, Isabelle, Castellant, Philippe, Moquet, Benoît, Druelles, Philippe, Rialan, Antoine, Rouault, Gilles, Boulanger, Bertrand, Treuil, Josiane, Leurent, Guillaume, Bedossa, Marc, Boulmier, Dominique, Avez, Bertrand, Gilard, Martine, and Le Breton, Hervé

Published
2016
Full Text
View/download PDF

46. A new phototherapy regimen during winter as an add-on therapy, coupled with oral vitamin D supplementation, for the long-term control of atopic dermatitis: study protocol for a multicentre, randomized, crossover, pragmatic trial – the PRADA trial

Author

Droitcourt, Catherine, Barbarot, Sébastien, Maruani, Annabel, Darrieux, Laure, Misery, Laurent, Brenaut, Emilie, Adamski, Henri, Chabbert, Cécile, Vermersch, Annie, Weiborn, Marie, Seneschal, Julien, Taïeb, Alain, Plantin, Patrice, Maillard, Hervé, Phan, Alice, Skowron, François, Viguier, Manuelle, Staumont-Salle, Delphine, Nosbaum, Audrey, Soria, Angèle, Barbaud, Annick, Oger, Emmanuel, Dupuy, Alain, and Groupe de Recherche sur l’Eczéma Atopique de la Société Française de Dermatologie (GREAT)

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results